HyugaLife raises Rs 100 crore in Series A to boost AI personalisation and offline expansion
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
nSEPIA aims to bring structure to an area long dominated by subjectivity
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
The conclave brought together over 1,000 delegates from across India and internationally
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Subscribe To Our Newsletter & Stay Updated